HomeEFTRW • OTCMKTS
add
eFFECTOR Therapeutics, Inc.
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.09M | 5.57% |
Net income | -8.83M | 11.78% |
Net profit margin | — | — |
Earnings per share | -2.16 | 64.00% |
EBITDA | -8.37M | 11.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.38M | 33.55% |
Total assets | 27.13M | 23.73% |
Total liabilities | 26.30M | -1.63% |
Total equity | 827.00K | — |
Shares outstanding | 4.70M | — |
Price to book | 0.00 | — |
Return on assets | -88.05% | — |
Return on capital | -117.18% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -8.83M | 11.78% |
Cash from operations | -7.28M | 4.70% |
Cash from investing | -6.32M | -170.02% |
Cash from financing | 14.23M | 6,613.21% |
Net change in cash | 633.00K | -60.49% |
Free cash flow | -3.83M | 1.77% |
About
Founded
2012
Headquarters
Website
Employees
14
